Clinical trial

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT01253902

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention bimatoprost ophthalmic solution 0.01% Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention travoprost ophthalmic solution 0.004% Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention latanoprost ophthalmic solution 0.005% Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-12-01

PhasePHASE4

Conditions

Glaucoma, Open-Anglecandidate · MONDO: open-angle glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

bimatoprost ophthalmic solution 0.01%DRUG

travoprost ophthalmic solution 0.004%DRUG

latanoprost ophthalmic solution 0.005%DRUG

Sponsors & collaborators

Allerganlead sponsor

Mapped research locations

CalgaryAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01253902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.